Syndax Pharmaceuticals, Inc. (SNDX)

Syndax Pharmaceuticals Stock Forecast

Stock Price Forecast

The 13 analysts that cover Syndax Pharmaceuticals stock have a consensus rating of "Strong Buy" and an average price target of $80.23, which forecasts a 288.15% increase in the stock price over the next year. The lowest target is $17 and the highest is $600.

Price Target: $80.23 (+288.15%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$17	$80.23	$38	$600
Change	-17.76%	+288.15%	+83.84%	+2802.8%

* Price targets were last updated on Jan 27, 2026.

Analyst Ratings

The average analyst rating for Syndax Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Sep '25	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26
Strong Buy	8	9	8	8	8	8
Buy	1	1	3	3	4	4
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	10	11	12	12	13	13

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Mara Goldstein Mizuho	Mizuho	Buy Maintains $410 → $600	Buy	Maintains	$410 → $600	+2,802.76%	Jan 27, 2026
Justin Zelin BTIG	BTIG	Strong Buy Reiterates $56	Strong Buy	Reiterates	$56	+170.92%	Dec 9, 2025
Etzer Darout Barclays	Barclays	Buy Maintains $22 → $35	Buy	Maintains	$22 → $35	+69.33%	Nov 24, 2025
Anupam Rama JP Morgan	JP Morgan	Buy Maintains $40 → $33	Buy	Maintains	$40 → $33	+59.65%	Nov 12, 2025
David Dai UBS	UBS	Strong Buy Maintains $35 → $38	Strong Buy	Maintains	$35 → $38	+83.84%	Nov 4, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

170.41M

Increased by 619.64%

from 23.68M

Revenue Next Year

368.01M

Increased by 115.96%

from 170.41M

EPS This Year

-3.19

from -3.72

EPS Next Year

-1.60

from -3.19

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	1.52M	139.71M	-	-	23.68M	170.41M	368.01M
Revenue Growth	-	9,109.56%	-	-	-	619.64%	115.96%
EPS	-1.87	0.46	-2.46	-2.98	-3.72	-3.19	-1.60
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	16	16

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029	2030
High	194.2M	475.6M
Avg	170.4M	368.0M
Low	155.9M	231.3M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029	2030
High	720.2%	179.1%
Avg	619.6%	116.0%
Low	558.4%	35.7%

EPS Forecast

EPS	2025	2026	2027	2028	2029	2030
High	-2.78	-0.55
Avg	-3.19	-1.60
Low	-3.35	-2.78

EPS Growth

EPS Growth	2025	2026	2027	2028	2029	2030
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.